In the light of these observations, coupling the antiangiogenic activity of 8a with NNMT inhibitors [63,64,65] may be a promising strategy to improve the outcome of patients with pancreatic cancer, a malignancy that displays little therapeutic options. This evidence concerns the gene NNMT and pancreatic neoplasm.